Overview

Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)

Status:
Recruiting
Trial end date:
2024-02-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to investigate treatment with psilocybin and psychotherapy for the treatment of people with Alcohol Use Disorder (AUD). The main question[s] it aims to answer are: - Does treatment with psilocybin and therapy help reduce alcohol consumption more than placebo and therapy? - Is treatment with psilocybin and therapy safe for participants? Participants will - Attend 13 study visits - Take part in therapy sessions including 2 treatment sessions with either psilocybin or placebo - Record their daily alcohol consumption on study specific device Researchers will compare psilocybin and placebo groups to see if alcohol consumption is decreased.
Phase:
Phase 2
Details
Lead Sponsor:
Clairvoyant Therapeutics
Collaborator:
Optimapharm
Treatments:
Psilocybin